X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5152) 5152
Book Review (774) 774
Publication (486) 486
Conference Proceeding (33) 33
Magazine Article (18) 18
Book Chapter (13) 13
Book / eBook (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4747) 4747
humans (4204) 4204
pyrazines - therapeutic use (2990) 2990
bortezomib (2735) 2735
male (2336) 2336
female (1911) 1911
middle aged (1567) 1567
animals (1540) 1540
boronic acids - therapeutic use (1528) 1528
pyrazines - pharmacology (1495) 1495
pyrazines - administration & dosage (1318) 1318
aged (1232) 1232
oncology (1229) 1229
multiple myeloma - drug therapy (1205) 1205
adult (1115) 1115
antineoplastic agents - therapeutic use (999) 999
boronic acids - administration & dosage (938) 938
antineoplastic combined chemotherapy protocols - therapeutic use (879) 879
hematology (877) 877
treatment outcome (877) 877
pyrazines - adverse effects (766) 766
multiple myeloma (751) 751
mice (711) 711
boronic acids - pharmacology (692) 692
pharmacology & pharmacy (667) 667
cancer (577) 577
sitagliptin phosphate (574) 574
apoptosis (573) 573
rats (519) 519
boronic acids - adverse effects (495) 495
cell line, tumor (469) 469
triazoles - therapeutic use (457) 457
antineoplastic agents - pharmacology (454) 454
protease inhibitors - therapeutic use (446) 446
diabetes mellitus, type 2 - drug therapy (443) 443
apoptosis - drug effects (441) 441
proteasome inhibitors (437) 437
therapy (437) 437
care and treatment (423) 423
dose-response relationship, drug (394) 394
research (381) 381
dexamethasone - administration & dosage (379) 379
thalidomide - analogs & derivatives (375) 375
drug therapy, combination (374) 374
hypoglycemic agents - therapeutic use (365) 365
aged, 80 and over (362) 362
multiple-myeloma (360) 360
abridged index medicus (358) 358
chemotherapy (357) 357
analysis (346) 346
clinical trials as topic (346) 346
drug therapy (321) 321
thalidomide - therapeutic use (318) 318
multiple myeloma - pathology (310) 310
thalidomide - administration & dosage (305) 305
dexamethasone (301) 301
thalidomide (287) 287
article (282) 282
nf-kappa-b (278) 278
antineoplastic agents - adverse effects (272) 272
recurrence (264) 264
stem-cell transplantation (264) 264
expression (262) 262
antineoplastic combined chemotherapy protocols - adverse effects (261) 261
medicine & public health (259) 259
pyrazines - chemistry (256) 256
time factors (254) 254
transplantation (250) 250
dipeptidyl-peptidase iv inhibitors - therapeutic use (249) 249
endocrinology & metabolism (249) 249
health aspects (244) 244
rats, sprague-dawley (243) 243
sitagliptin (239) 239
biochemistry & molecular biology (236) 236
prognosis (232) 232
multiple myeloma - therapy (230) 230
cells (226) 226
activation (221) 221
proteasome inhibitor bortezomib (218) 218
dosage and administration (216) 216
pyrazines - pharmacokinetics (215) 215
survival (213) 213
trial (212) 212
antineoplastic agents - administration & dosage (210) 210
cell proliferation - drug effects (210) 210
protease inhibitors - pharmacology (209) 209
proteins (209) 209
hematology, oncology and palliative medicine (208) 208
retrospective studies (208) 208
type 2 diabetes (208) 208
disease models, animal (207) 207
chemistry, medicinal (205) 205
proteasome endopeptidase complex - metabolism (205) 205
medicine, general & internal (202) 202
dexamethasone - therapeutic use (201) 201
drug administration schedule (199) 199
drug synergism (199) 199
multiple myeloma - complications (196) 196
drug resistance, neoplasm (193) 193
multiple myeloma - mortality (190) 190
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4586) 4586
Chinese (136) 136
French (108) 108
Japanese (83) 83
Italian (66) 66
German (63) 63
Spanish (34) 34
Czech (21) 21
Russian (18) 18
Polish (17) 17
Dutch (10) 10
Hungarian (10) 10
Portuguese (6) 6
Swedish (6) 6
Danish (4) 4
Norwegian (4) 4
Hebrew (2) 2
Slovak (2) 2
Turkish (2) 2
Finnish (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Cell, ISSN 1535-6108, 09/2012, Volume 22, Issue 3, pp. 345 - 358
Bortezomib therapy has proven successful for the treatment of relapsed/refractory, relapsed, and newly diagnosed multiple myeloma (MM); however, dose-limiting... 
DEUBIQUITINATING ENZYME | INACTIVATION | PROTEIN | THERAPY | ONCOLOGY | MDM2 | DEGRADATION | MECHANISMS | HAUSP | CANCER | P53 REGULATION | CELL BIOLOGY | Thiophenes - therapeutic use | Apoptosis - drug effects | Humans | Molecular Sequence Data | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Thalidomide - pharmacology | Boronic Acids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Protease Inhibitors - pharmacology | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Multiple Myeloma - enzymology | Protease Inhibitors - therapeutic use | Proto-Oncogene Proteins c-mdm2 - metabolism | Ubiquitin Thiolesterase - antagonists & inhibitors | Bortezomib | Cyclin-Dependent Kinase Inhibitor p21 - antagonists & inhibitors | Thiophenes - pharmacology | Random Allocation | Mice, SCID | Ubiquitin Thiolesterase - genetics | Xenograft Model Antitumor Assays | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Mice | Thalidomide - therapeutic use | Pyrazines - pharmacology | Ubiquitin-Specific Peptidase 7 | Boronic Acids - pharmacology | Drug Resistance, Neoplasm - drug effects | Medical colleges | Dexamethasone | Proteases | Analysis | Multiple myeloma | Lymphomas | Apoptosis | Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 02/2012, Volume 35, Issue 2, pp. 252 - 258
Journal Article
Blood, ISSN 0006-4971, 08/2012, Volume 120, Issue 8, pp. 1589 - 1596
The Spanish Myeloma Group conducted a trial to compare bortezomib/thalidomide/dexamethasone (VTD) versus thalidomide/dexamethasone (TD) versus vincristine,... 
TRIAL | SURVIVAL | PLUS DEXAMETHASONE | COMPLETE REMISSION | HIGH-DOSE THERAPY | COMPLETE RESPONSE | DOXORUBICIN | PERIPHERAL NEUROPATHY | CONTINUED STANDARD CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Boronic Acids - toxicity | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Pyrazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Boronic Acids - adverse effects | Dexamethasone - adverse effects | Dexamethasone - toxicity | Induction Chemotherapy | Male | Transplantation, Autologous | Antineoplastic Agents - therapeutic use | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Boronic Acids - therapeutic use | Antineoplastic Agents - toxicity | Multiple Myeloma - therapy | Pyrazines - toxicity | Antineoplastic Agents - adverse effects | Female | Boronic Acids - administration & dosage | Thalidomide - adverse effects | Bortezomib | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Thalidomide - administration & dosage | Thalidomide - toxicity | Antineoplastic Combined Chemotherapy Protocols - toxicity | Disease-Free Survival | Dexamethasone - therapeutic use | Multiple Myeloma - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Pyrazines - adverse effects | Stem Cells - drug effects | Stem Cells - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Thalidomide - therapeutic use | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 944 - 953
Journal Article
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 10/2012, Volume 35, Issue 10, pp. 2076 - 2082
Journal Article